Bullish Case: KMB's term structure is backwardated—near-term Helium-traced vols spike to ~49.5% (9/19) while later tenors sit ~21–23%—meaning short-dated protection is expensive and event risk is front-loaded. If the China disruption stabilizes and Q3 (late October) confirms productivity-led EPS growth, expensive puts decay and the stock's mean-reverting history supports a drift back toward $105–110, aligning with the $117.47 analyst mean target.

Bearish Case: KMB is down ~22% year-over-year, -10.3% in a month, with put volume 87% above calls and 9% more bearish than bullish risk across tenors. The Helium price-density peak sits at $98–99 with fat left tails at 90–95, and market density shows spikes at 90–95—downside tail is actively priced. A cut 2026 outlook and China sales disruption could extend the slide below $95.

Potential Outcomes:

1. 38% Stabilization/mean reversion: holds ≥95, China drag fades, drift to 102–108 by December (backwardation unwinds; falsified if 95P IV stays >30%).
2. 30% Continued slide: breaks <95, Q3 organic sales miss again; 88–93 by Q3 print (put-skew steepens further).
3. 17% Chop: 95–102 range, vol bleeds into Jan-2027 expiry.
4. 10% Bullish catalyst: China recovery or synergy/M&A headline; +8–12% toward 110+ (Oct 113C flow hints at this).
5. 5% Tail shock: SPY vol spikes, KMB <85 (deep-put 75P/80P IV ~29–35% prices this).

September 12, 2026